NCT03629522View on ClinicalTrials.gov

Effects of Ondansetron on Hemodynamics in Cesarean Section Under Spinal Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

November 30, 2017

Study Completion Date

December 30, 2017

Conditions
OndansetronCesarean SectionSpinal AnesthesiaHemodynamics
Interventions
DRUG

Ondansetron 8Mg/4mL Injection

investigators administrated intravenously Ondansetron 8 mg 5 minutes before spinal anesthesia.

Trial Locations (2)

1002

Ministry of Health, Tunis

5100

Mahdia University Hospital, Mahdia

All Listed Sponsors
lead

University Hospital, Mahdia

OTHER

NCT03629522 - Effects of Ondansetron on Hemodynamics in Cesarean Section Under Spinal Anesthesia | Biotech Hunter | Biotech Hunter